QEDDI’s pipeline is targeting new treatments for unmet medical needs, including cancer, inflammatory disorders and neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease.

Unique partnering opportunities are available from QEDDI’s pipeline of novel therapeutic, validated and de-risked drug leads based on innovative biological research targeting new treatments for some of the world’s most challenging diseases, including cancer, inflammatory disorders and neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease.

QEDDI’s pipeline of projects is accompanied by high-quality data packages and solid IP protection strategies.